I have been harping on getting the BOM2 going and funded in US and hoping to hear very soon. Weeks not months. It is time to get this trial going helped along and piggybacking of the BTD and previous trial successes and some guidance from the FDA this time. Trial design is critical,  shoot for endpoints of P that will get us FDA approval. We have enough successful independent research now is the time to prove it out. At this point that is what will move market cap. into the multiple Billions of $'s. COVID is interesting and something they had to pursue and if it works good also had lots to market cap. Those are top priorities are the rest is window dressing, in my opinion of course. If they need financial advice lots of top notch help that would be glad to earn a fee to bring in additional capital. In fact I bet Eversana has some earmarked already.